Strategies for treatment of generalized anxiety in the primary care setting

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 3, 1997, Pages 27-33

  Schweizer, Edward ^a   Rickels, Karl ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BUSPIRONE; DIAZEPAM; IMIPRAMINE; LORAZEPAM; TRAZODONE;

ANXIETY NEUROSIS; COGNITIVE THERAPY; DOSE RESPONSE; HUMAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW;

ANXIETY DISORDERS; BENZODIAZEPINES; BUSPIRONE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; HUMANS; IMIPRAMINE; PRIMARY HEALTH CARE; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 0031004330     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Robins LE, Regier DA, eds. Psychiatric Disorders in America: the Epidemiologic Catchment Area Study. New York, NY: The Free Press; 1991
2. Katon W, Von Korff M, Lin E, et al. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990;12:355-362
3. Rickels K, Schweizer E. Maintenance treatment studies in anxiety disorders: some methodological notes. Psychopharmacol Bull 1995;31:115-123
4. Uhlenhuth EH, Rickels K, Fisher S, et al. Drug: doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia 1966;9:392-118
5. Gath D, Catalan J. The treatment of emotional disorders in general practice: psychological methods versus medication. J Psychosom Res 1986;30:381-386
6. Davidson TL, Lucki I. The long-term effects of diazepam and pentylenetetrazol on behavioral sensitivity to a stressor. Pharmacol Biochem Behav 1987;27:99-103
7. Rickels K, Wiseman K, Norstad N, et al. Buspirone and diazepam in anxiety: a controlled study. J Clin Psychiatry 1982;43(12, sec 2):81-86
8. Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 1993;50: 884-895
9. Rickels K, Fox IL, Greenblatt DJ, et al. Clorazepate and lorazepam: clinical-improvement and rebound anxiety. Am J Psychiatry 1988;145(3): 312-317
10. Robinson DS, Rickels K, Feighner J, et al. Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 1990;10:67S-76S
11. Schweizer E, Rickels K. Failure of buspirone to manage benzodiazepine withdrawal. Am J Psychiatry 1986;143:1590-1592
12. Olajide D, Lader MA. A comparison of buspirone, diazepam and placebo in patients with chronic anxiety states. J Clin Psychopharmacol 1987;7: 148-152
13. Udelman HD, Udelman DL. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy. J Clin Psychiatry 1990; 51(9, suppl):46-50
14. Chiaie RD, Pancheri P, Casacchia M, et al. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study. J Clin Psychopharmacol 1995;15(1):12-18